|
RAD9B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59010005162941E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.29859999975501E-07 |
| Normal-vs-Stage2 |
1.260920E-03 |
| Normal-vs-Stage3 |
1.752069999994E-05 |
| Normal-vs-Stage4 |
2.43779999999916E-05 |
| Stage1-vs-Stage2 |
8.538200E-01 |
| Stage1-vs-Stage3 |
6.362800E-01 |
| Stage1-vs-Stage4 |
5.332800E-01 |
| Stage2-vs-Stage3 |
8.866400E-01 |
| Stage2-vs-Stage4 |
7.882800E-01 |
| Stage3-vs-Stage4 |
8.826800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.15839998599188E-09 |
| Normal-vs-AfricanAmerican |
1.999130E-04 |
| Normal-vs-Asian |
2.964700E-03 |
| Caucasian-vs-AfricanAmerican |
9.547600E-01 |
| Caucasian-vs-Asian |
5.789200E-01 |
| AfricanAmerican-vs-Asian |
5.426400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00370000089001E-08 |
| Normal-vs-Female |
4.81109999617146E-08 |
| Male-vs-Female |
8.863200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.694100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.97600003026821E-09 |
| Normal-vs-Age(61-80Yrs) |
3.92869999976675E-07 |
| Normal-vs-Age(81-100Yrs) |
1.000100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.287200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.753800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.725200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.087800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.698400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.607000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.07319999999678E-05 |
| Normal-vs-Grade 2 |
1.10329999580827E-08 |
| Normal-vs-Grade 3 |
4.62220000052582E-08 |
| Normal-vs-Grade 4 |
2.377300E-03 |
| Grade 1-vs-Grade 2 |
1.984160E-01 |
| Grade 1-vs-Grade 3 |
2.463200E-01 |
| Grade 1-vs-Grade 4 |
1.105220E-01 |
| Grade 2-vs-Grade 3 |
9.684600E-01 |
| Grade 2-vs-Grade 4 |
2.635200E-01 |
| Grade 3-vs-Grade 4 |
2.909800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.97840000049077E-07 |
| Normal-vs-ccB subtype |
3.36999999994703E-06 |
| ccA subtype-vs-ccB subtype |
8.166200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.04610000451322E-08 |
| Normal-vs-N1 |
1.754070E-02 |
| N0-vs-N1 |
2.316000E-01 |
|
|
